Since it is known that functional inhibitors of SMPD1, such as imipramine, are capable of reducing hepatic fibrosis, we were interested whether desipramine, also a functional inhibitor, is capable to reduce hepatic fibrosis occurring in sepsis survivors as a long-term sequela. Here, SMPD1 is linked to Hepatic fibrosis.